Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 293-294, 2005; 10.1373/clinchem.2004.044388
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curhan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curhan, G.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Proteomics and Protein Markers
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
Right arrow Current Issues in Laboratory Medicine
(Clinical Chemistry. 2005;51:293-294.)
© 2005 American Association for Clinical Chemistry, Inc.

Editorials

Cystatin C: A Marker of Renal Function or Something More?

Gary Curhan

1 Brigham and Women’s Hospital, Boston, MA 02115

aE-mail gary.curhan@channing.harvard.edu

The first 300 words of the full text of this article appear below.

Over the past decade, we have come to appreciate that individuals with even moderately reduced renal function are at increased risk for cardiovascular morbidity and mortality. There is no consensus, however, on how renal function should be measured. The most precise and accurate methods (such as inulin clearance) are impractical in the clinical setting and for larger research studies. Serum creatinine has been the mainstay by which renal function has been estimated for decades, but it is crude and can often be misleading. Age, weight, sex, and race influence creatinine production and thus need to be taken into account when evaluating a serum creatinine value. For example, an elderly woman with a serum creatinine in the "normal" range can have severely reduced renal function. Although measurements of serum creatinine are relatively inexpensive and widely available, they do have limitations.

In an attempt to address some of these limitations, equations have been derived to estimate either creatinine clearance or the glomerular filtration rate (GFR). The most commonly used equation for estimating creatinine clearance is the Cockcroft–Gault formula (1). GFR calculated by this equation correlates well with measured GFR when renal function is within the reference interval, but as renal function declines, it overestimates GFR because creatinine is removed not only by glomerular filtration by also by renal tubular secretion. When GFR is low, tubular secretion becomes an important factor. Another formula, the MDRD (Modification of Diet in Renal Disease) equation, is the most widely used to estimate GFR (2). It too has several limitations, including lack of validation within the reference interval, the susceptibility of the alkaline-picrate creatinine method to interferences, and the lack of harmonization of creatinine assays. The variation between laboratories for plasma creatinine may be 30% or more. This has serious implications when using . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 Nephrol Dial TransplantHome page
D. Singh, M. A. Whooley, J. H. Ix, S. Ali, and M. G. Shlipak
Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1087 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. Pucci, S. Triscornia, D. Lucchesi, C. Fotino, G. Pellegrini, E. Pardini, R. Miccoli, S. Del Prato, and G. Penno
Cystatin C and Estimates of Renal Function: Searching for a Better Measure of Kidney Function in Diabetic Patients
Clin. Chem., March 1, 2007; 53(3): 480 - 488.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
K. Bibbins-Domingo, G. M. Chertow, L. F. Fried, M. C. Odden, A. B. Newman, S. B. Kritchevsky, T. B. Harris, S. Satterfield, S. R. Cummings, and M. G. Shlipak
Renal function and heart failure risk in older black and white individuals: the health, aging, and body composition study.
Arch Intern Med, July 10, 2006; 166(13): 1396 - 1402.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. G. Shlipak, C. L. W. Fyr, G. M. Chertow, T. B. Harris, S. B. Kritchevsky, F. A. Tylavsky, S. Satterfield, S. R. Cummings, A. B. Newman, and L. F. Fried
Cystatin C and Mortality Risk in the Elderly: The Health, Aging, and Body Composition Study
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 254 - 261.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.